Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...

It was an illuminating moment, not just an amusing line. Every new administration has factions that end up hating one another despite being on the same official team. But the second Trump White House ...

In a groundbreaking announcement, former President Donald Trump has unveiled an ambitious $500 billion plan aimed at pioneering a cancer vaccine that could change the landscape of treatment for ...

Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 16,974 calls trading, 1.0x expected, and implied vol increasing over 12 ...

The president joined leaders from OpenAI, Oracle and SoftBank to launch the ambitious project, but questions remain about its ...

RNA vaccine developer Moderna (MRNA) is sinking 9% after Goldman Sachs downgraded the shares to Neutral from Buy. Why Goldman ...

In 2025, the AI landscape is undergoing a transformative shift, expanding into two critical new layers: the application layer ...

Goldman Sachs analyst Salveen Richter downgraded Moderna (NASDAQ:MRNA) stock from Buy to Neutral, significantly reducing the price target to $51 from the previous $99. Trading at $44.94, the stock has ...

Detailed price information for Moderna Inc (MRNA-Q) from The Globe and Mail including charting and trades.

One day after being sworn in as the 47th president of the United States, Donald Trump revealed the creation of Stargate, a ...

NBC News' Ellison Barber gets a firsthand look at the coordinated effort to battle the Los Angeles wildfires from the sky with Cal Fire.Jan. 15, 2025 ...

After the president held a White House event announcing a shared venture, with up to $500 billion of funding, among OpenAI, ...